Hyperbaric oxygen exposure alleviate metabolic side-effects of olanzapine treatment and is associated with Langerhans islet proliferation in rats
Introduction: Olanzapine (OLZ) is one of the second-generation antipsychotics drugs (APDs) used to treat several psychiatric illnesses. Olanzapine treatment is often associated with many metabolic side effects in a dose dependent manner such as obesity, dyslipidemia and insulin resistance, induction...
Main Authors: | Mohammad AlQudah, Mohammad Khalifeh, Rasha Al-Azaizeh, Amr Masaadeh, Omar M. Al-Rusan, Husam K. Haddad |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Pathology and Oncology Research |
Subjects: | |
Online Access: | https://www.por-journal.com/articles/10.3389/pore.2022.1610752/full |
Similar Items
-
Transplantation or islets of Langerhans: new developments
by: A Caulfield, et al.
Published: (2001-12-01) -
Enhancing the aqueous solubility and dissolution of olanzapine using freeze-drying
by: Mudit Dixit, et al.
Published: (2011-12-01) -
LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN
by: MAZIN F. AL-JADIRY, et al.
Published: (2008-10-01) -
Using of Third and Fourth Order Derivative Spectra to Simultaneous Determination of Olanzapine and Ephedrine in Its Pure and Pharmaceutical Formulations
by: Mumin F. Hamad Al-Samarrai, et al.
Published: (2017-06-01) -
Report of a Rare Case of Olanzapine and Risperidone Induced Hypomania
by: AR Zahiroddin, et al.
Published: (2006-07-01)